Kim Thys

机构：Johnson & Johnson (United States), Janssen (Belgium), Johnson & Johnson (Brazil) · ORCID：0000-0002-0400-6915

发表论文 57 篇 · 总被引 1804 次 · h-index 19

代表论文

• A pan-serotype dengue virus inhibitor targeting the NS3–NS4B interaction (2021 · Nature · 被引 199)
• High-Throughput Analysis of Human Cytomegalovirus Genome Diversity Highlights the Widespread Occurrence of Gene-Disrupting Mutations and Pervasive Recombination (2015 · Journal of Virology · 被引 199)
• Blocking NS3–NS4B interaction inhibits dengue virus in non-human primates (2023 · Nature · 被引 133)
• Publisher Correction: A pan-serotype dengue virus inhibitor targeting the NS3–NS4B interaction (2021 · Nature · 被引 31)
• Performance assessment of the Illumina massively parallel sequencing platform for deep sequencing analysis of viral minority variants (2015 · Journal of Virological Methods · 被引 31)
• Single‐cell immune profiling reveals markers of emergency myelopoiesis that distinguish severe from mild respiratory syncytial virus disease in infants (2023 · Clinical and Translational Medicine · 被引 16)